국가: 네덜란드
언어: 네덜란드어
출처: CBG-MEB (College ter Beoordeling van Geneesmiddelen)
TACROLIMUS 1-WATER 1,022 mg/stuk SAMENSTELLING overeenkomend met ; TACROLIMUS 0-WATER 1 mg/stuk
Sandoz B.V. Veluwezoom 22 1327 AH ALMERE
L04AD02
TACROLIMUS 1-WATER 1,022 mg/stuk SAMENSTELLING overeenkomend met ; TACROLIMUS 0-WATER 1 mg/stuk
Capsule, hard
CROSCARMELLOSE NATRIUM (E 468) ; GELATINE (E 441) ; HYPROMELLOSE (E 464) ; IJZEROXIDE GEEL (E 172) ; IJZEROXIDE ROOD (E 172) ; IJZEROXIDE ZWART (E 172) ; LACTOSE 1-WATER ; MAGNESIUMSTEARAAT (E 470b) ; NATRIUMLAURILSULFAAT ; SORBITANMONOLAURAAT (E 493) ; TITAANDIOXIDE (E 171), CROSCARMELLOSE NATRIUM (E 468) ; GELATINE (E 441) ; HYPROMELLOSE (E 464) ; IJZEROXIDE GEEL (E 172) ; IJZEROXIDE ROOD (E 172) ; IJZEROXIDE ZWART (E 172) ; LACTOSE 1-WATER ; MAGNESIUMSTEARAAT (E 470b) ; NATRIUMLAURILSULFAAT (E 487) ; SORBITANMONOLAURAAT (E 493) ; TITAANDIOXIDE (E 171),
Oraal gebruik
Tacrolimus
Hulpstoffen: CROSCARMELLOSE NATRIUM (E 468); GELATINE (E 441); HYPROMELLOSE (E 464); IJZEROXIDE GEEL (E 172); IJZEROXIDE ROOD (E 172); IJZEROXIDE ZWART (E 172); LACTOSE 1-WATER; MAGNESIUMSTEARAAT (E 470b); NATRIUMLAURILSULFAAT (E 487); SORBITANMONOLAURAAT (E 493); TITAANDIOXIDE (E 171);
2009-12-22
Sandoz B.V. Page 1 Tacrolimus Sandoz 0,5 mg, 0,75 mg, 1 mg, 2 mg, 5 mg, capsules, hard RVG 102096/113454/102097/113453/102098 1313-v14 1.3.1.3 Bijsluiter Mei 2022 BIJSLUITER: INFORMATIE VOOR DE PATIËNT TACROLIMUS SANDOZ® 0,5 MG, CAPSULES, HARD TACROLIMUS SANDOZ® 0,75 MG, CAPSULES, HARD TACROLIMUS SANDOZ® 1 MG, CAPSULES, HARD TACROLIMUS SANDOZ® 2 MG, CAPSULES, HARD TACROLIMUS SANDOZ® 5 MG, CAPSULES, HARD tacrolimus _ _ READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. − Keep this leaflet. You may need to read it again. − If you have any further questions, ask your doctor or pharmacist. − This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. − If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What [Nationally completed name] is and what it is used for 2. What you need to know before you take [Nationally completed name] 3. How to take [Nationally completed name] 4. Possible side effects 5. How to store [Nationally completed name] 6. Contents of the pack and other information 1. WHAT [NATIONALLY COMPLETED NAME] IS AND WHAT IT IS USED FOR [Nationally completed name] belongs to a group of medicines called IMMUNOSUPPRESSANTS . Following your organ transplant (e.g. liver, kidney, heart), your body’s immune system will try to reject the new organ. [Nationally completed name] is used to control your body’s immune response enabling your body to accept the transplanted organ. [Nationally completed name] is often used in combination with other medicines that also suppress the immune system. You may also be given [Nationally completed name] for an ongoing rejection of your transplanted liver, kidney, heart or other organ or if any previous treatment you were taking was unable to control this immune response after your tra 전체 문서 읽기
Sandoz B.V. Page 1 Tacrolimus Sandoz 0,5 mg, 0,75 mg, 1 mg, 2 mg, 5 mg, capsules, hard RVG 102096, 113454, 102097, 113453, 102098 1311-v15 1.3.1.1 Summary of Product Characteristics Mei 2022 1 NAAM VAN HET GENEESMIDDEL Tacrolimus Sandoz 0,5 mg, capsules, hard Tacrolimus Sandoz 0,75 mg, capsules, hard Tacrolimus Sandoz 1 mg, capsules, hard Tacrolimus Sandoz 2 mg, capsules, hard Tacrolimus Sandoz 5 mg, capsules, hard 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each hard capsule contains 0.5 mg of tacrolimus (as tacrolimus monohydrate). Excipient with known effect: Each hard capsule contains 46.1 mg lactose (as monohydrate). Each hard capsule contains 0.75 mg of tacrolimus (as tacrolimus monohydrate). Excipient with known effect: Each hard capsule contains 69.1 mg lactose (as monohydrate). Each hard capsule contains 1 mg of tacrolimus (as tacrolimus monohydrate). Excipient with known effect: Each hard capsule contains 45.0 mg lactose (as monohydrate). Each hard capsule contains 2 mg of tacrolimus (as tacrolimus monohydrate). Excipient with known effect: Each hard capsule contains 90.0 mg lactose (as monohydrate). Each hard capsule contains 5 mg of tacrolimus (as tacrolimus monohydrate). Excipient with known effect: Each hard capsule contains 225.1 mg lactose (as monohydrate). For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Sandoz B.V. Page 2 Tacrolimus Sandoz 0,5 mg, 0,75 mg, 1 mg, 2 mg, 5 mg, capsules, hard RVG 102096, 113454, 102097, 113453, 102098 1311-v15 1.3.1.1 Summary of Product Characteristics Mei 2022 Capsule, hard _0.5 mg hard capsules _ Opaque white and ivory hard gelatin capsule containing white to off- white powder (length: 14.5 mm). _0.75 mg hard capsules _ Light green opaque hard gelatin capsule, imprinted in black with 0.75 mg on the cap, containing white to off-white powder (length: 14.5 mm). _1 mg hard capsules _ Opaque white and light brown hard gelatin capsule containing white to off- white powder (length: 14.5 mm). _2 mg hard capsules _ Dark green opaque capsule, imprinted 전체 문서 읽기